Polyphenols, isothiocyanates, and carotenoid derivatives enhance estrogenic activity in bone cells but inhibit it in breast cancer cells

Polyphenols, isothiocyanates, and carotenoid derivatives enhance
estrogenic activity in bone cells but inhibit it in breast cancer cells. Am J
Physiol Endocrinol Metab 303: E815–E824, 2012. First published August
30, 2011; doi:10.1152/ajpendo.00142.2011.—While exposure to estrogens is a major risk factor of breast and endometrial cancer, it well
established that estrogens are beneficial for bone health. We have
previously shown that carotenoids inhibit estrogen signaling in breast
and endometrial cancer cells. The aim of this study was to compare
the effects of various phytonutrients, (carotenoid derivatives, polyphenols, isothiocyanates) on estrogenic activity in breast cancer cells
and osteoblast-like cells. All the tested phytonutrients inhibited estrogen response element (ERE) transactivation in breast cancer cells. In
contrast, these compounds either did not affect or enhanced ERE
activity and the expression of several bone-forming genes. These
results were obtained using two osteoblast-like cell lines, MG-63
human osteosarcoma cells stably transfected with estrogen receptor-
(ER) and MC3T3-E1 mouse calvaria-derived cells expressing endogenous ER. Phytonutrients-induced ERE inhibition in breast cancer
cells, and its potentiation in osteoblast-like cells were associated both
with a decrease and a rise in total and nuclear ER levels, respectively. Phytonutrients activated the electrophile/antioxidant response
element (EpRE/ARE) transcription system to various extents in both
cancer and bone cell lines. Overexpression of Nrf2, the major EpRE/
ARE activating transcription factor, mimicked the effects of phytonutrients, causing inhibition and enhancement of ERE transactivation
in breast cancer cells and in osteoblast-like cells, respectively. Moreover, reduction in Nrf2 levels by RNAi led to a decrease in the
phytonutrient potentiation of ERE activity transactivation in osteoblast-like cells. These findings suggest that the enhancement and
inhibition of estrogen signaling by phytonutrients in bone-derived
cells and breast cancer cells, respectively, is partially mediated by the
activation of the Nrf2/ARE system.

File Type: 2011
Categories: Lycomato
Tags: Women's Health

Continue reading

August 2025 Newsletter – Shine with Lycored’s Food and Health Innovation

Lumenato’s EFSA approval The European Food Safety Authority (EFSA) Panel on Nutrition, Novel Foods, and Food Allergens has issued a positive scientific opinion on Lumenato™, affirming its safety as a...

4 trends at IFT First sending food formulators back to the drawing board

Lycored Unveils Superstable Color Emulsions at IFT FIRST: A New Era for Nature-Based Food Colors

Lycored, a global leader in naturally derived carotenoids, is celebrating its 30th anniversary with a vibrant innovation: the launch of three superstable, nature-based color emulsions. Introduced at the IFT FIRST...

We're here for you

Interested in speaking directly with a member of our team?
Click below to get in touch.

Contact us